ImCheck Therapeutics
Marseille
About ImCheck Therapeutics
ImCheck Therapeutics is a developer of immunomodulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric and ovarian cancer cells, and other solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $207.8M
- Funding stage: M&A
- Last round: Grant (Aug 2024)
- Website: imchecktherapeutics.com
- Phone: +33 4 13 96 14 90
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/imcheck-therapeutics-93408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.